1. Kisliuk R. L. “Folate biochemistry in relation to antifolate selectivity.” In Anticancer Drug Development Guide: Antifolate Drugs in Cancer Therapy, A. L. Jackman, ed., Humana Press Inc.,Totowa, NJ, pp. 13–36, 1999.
2. McGuire J. J. and Coward J. K. “Pteroylpolyglutamates: biosynthesis, degradation and function.” In R. L. Blakley and S.J. Benkovic, eds., Folates and Pterins: Chemistry and Biochemistry of Folates, John Wiley, New York, NY, vol. 1, pp. 135–190, 1984.
3. Shane B. Folylpolyglutamate synthesis and role in the regulation of one-carbon metabolism. Vitam Horm 45: 263–335, 1989.
4. Galivan J., Ryan T.J., Chave K., Rhee M., Yao R., Yin D., Glutamyl hydrolase: pharmacological role and enzymatic characterization. Pharmacol Ther 85: 207–215, 2000.
5. Cole P. D., Kamen B. A., Gorlick R., Bannerjee D., Smith A. K., Magill E., Bertino J. R. Effects of overexpression of gamma-glutamyl hydrolase on methotrexate metabolism and resistance. Cancer Res 61: 4599–4604, 2001.